Vagi-cure (regular Strength)
NDC Package 76466-075-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vagi-cure (regular Strength) is a . Marketed by Sci International, Inc. Dba Continental Pharmaceuticals, this product is identified by NDC 76466-075 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
76466-075-07
Package Description
21 g in 1 TUBE
Product Code
76466-075
11-Digit Billing Format
76466007507

Clinical Specifications

Proprietary Name
Vagi-cure (regular Strength)
Dosage Form
-

Regulatory & Marketing

Labeler Name
Sci International, Inc. Dba Continental Pharmaceuticals
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2011
End Marketing Date
01-01-2023
Listing Expiration
01-01-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76466-075-07 identifies a specific commercial package of 21 g in 1 tube of Vagi-cure (regular Strength), labeled by Sci International, Inc. Dba Continental Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sci International, Inc. Dba Continental Pharmaceuticals on January 01, 2011. The current certification is valid through January 01, 2023.

How is this Sci International, Inc. Dba Continental Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76466007507. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76466-075-07
11-Digit CMS (5-4-2)
76466-0075-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.